World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
6992
World Ranking
17361
National Ranking
7134

Ranajit Pal publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ranajit Pal sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 136 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ranajit Pal D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ranajit Pal sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ranajit Pal is affiliated with Advanced Bioscience Laboratories in the United States. Their research spans several fields including Medicine and Immunology and Microbiology, with a strong focus on immunology as well as epidemiology and virology. The scientist's work addresses multiple topics such as HIV research and treatment, biomedical research and pathophysiology, neonatal health and biochemistry, reproductive system and pregnancy, immune cell function and interaction, immune responses and vaccinations, and virology and viral diseases.

Their publication record includes papers in notable journals and venues. These include:

  • Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition, 2020, PLoS Pathogens
  • Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type, 2020, PLoS Pathogens
  • In vitro activity of cysteamine against SARS-CoV-2 variants, 2022, Molecular Genetics and Metabolism
  • Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates, 2024, Vaccine
  • In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors with whom Ranajit Pal has collaborated include Lauren Wattay, Maria Grazia Ferrari, Giacomo Gorini, Monica Vaccari, and Dallas R. Brown. The scientist's work is often published in venues such as PLoS Pathogens, Molecular Genetics and Metabolism, Vaccine, and bioRxiv.

The research topics Ranajit Pal investigates cover areas critical to understanding infectious diseases and immune responses, with specific emphasis on vaccine efficacy, viral variants, and immune cell interactions during viral infections. Their focus on both basic and applied research links immunological mechanisms with clinical challenges in infectious disease management and prevention.

Best Publications

  • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

    P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Inhibition of HIV-1 Infection by the β-Chemokine MDC

    Ranajit Pal;Alfredo Garzino-Demo;Phillip D. Markham;Jennifer Burns

  • Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers

    Shixia Wang;Jeffrey S. Kennedy;Kim West;David C. Montefiori

  • Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial

    Poonam Pegu;Monica Vaccari;Shari Gordon;Brandon F. Keele

  • Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus

    Laurel A Lagenaur;Brigitte E Sanders-Beer;Beda Brichacek;Ranajit Pal

  • Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

    Timothy Fouts;Karla Godfrey;Kathryn Bobb;David Montefiori

  • Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E

    Shixia Wang;Ranajit Pal;John R. Mascola;Te-Hui W. Chou

  • Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa

    Igor M. Belyakov;Vladimir A. Kuznetsov;Brian Kelsall;Dennis Klinman

  • Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.

    Susan W Barnett;Indresh K Srivastava;Elaine Kan;Fengmin Zhou

  • Myristoylation of gag Proteins of HIV-1 Plays an Important Role in Virus Assembly

    Ranajit Pal;Marvin S. Reitz;Erwin Tschachler;R.C. Gallo

  • Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.

    Ranajit Pal;George M. Hoke;M. G. Sarngadharan

  • Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

    Ranajit Pal;Shixia Wang;V.S. Kalyanaraman;B.C. Nair

  • Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251 Challenge

    Peng Xiao;L. Jean Patterson;Seraphin Kuate;Egidio Brocca-Cofano

  • Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

    Timothy R. Fouts;Kenneth Bagley;Ilia J. Prado;Kathryn L. Bobb

  • A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

    Thorsten Demberg;Ruth H. Florese;Megan J. Heath;Kay Larsen

  • Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.

    C. A. Stein;Ranajit Pal;A. L. Devico;G. Hoke

  • Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

    Joseph W. Romano;Roxanne N. Shurtliff;Eric Dobratz;Andrew Gibson

  • Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation

    Margherita Rosati;Antonio Valentin;Rashmi Jalah;Vainav Patel

  • Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.

    C. A. Stein;L. M. Neckers;B. C. Nair;S. Mumbauer

Frequent Co-Authors

David C. Montefiori
David C. Montefiori Duke University
Vaniambadi S. Kalyanaraman
Vaniambadi S. Kalyanaraman North Shore University Hospital
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
David Venzon
David Venzon National Institutes of Health
Robert C. Gallo
Robert C. Gallo University of South Florida
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
M. G. Sarngadharan
M. G. Sarngadharan AkzoNobel (Netherlands)
Anthony L. DeVico
Anthony L. DeVico University of Maryland, Baltimore
Celia C. LaBranche
Celia C. LaBranche Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ranajit Pal

Trending Scientists

Recently Published Articles